Cycling

Cycling great Greg LeMond reveals cancer diagnosis

US biking great Greg LeMond, a three-time Tour de France winner, has revealed he’s receiving therapy for leukemia.

FOR THE VERY LATEST CYCLING NEWS PLEASE VISIT THE SOUTH AFRICAN WEBSITE

“I have been diagnosed with Chronic Myelogenous Leukemia,” LeMond, 60, stated in a press release on his website.

“Fortunately, it is a type of cancer that is treatable, and it is a type of leukemia that is not life-threatening or debilitating.”

The former two-time world champion stated “a few weeks of fatigue” had prompted him to go for a check-up.

“Following a series of tests and a bone marrow biopsy, which was completed last week, I received my formal diagnosis last Friday,” he stated.

“My docs on the University of Tennessee, with session from a staff on the Mayo Clinic, have outlined a chemotherapy protocol which is able to start this week.

“The long-term prognosis is very favorable. I am fortunate to have a great team of doctors and the full support of my family, friends and colleagues at LeMond Bicycles.”

Greg Lemond confirmed that he wouldn’t be travelling to the Tour de France this 12 months the place he has labored with a number of media retailers since his retirement in 1994.

“I had hoped to be in France in July for the Tour, but we are, now, working on an alternate plan so I can follow the Tour and engage with friends and teammates from our offices and farm in Tennessee. I will look forward to returning to the Tour next summer,” he added.

Greg LeMond is the one official American Tour de France winner

LeMond was the primary American to win the Tour de France, in 1986. The sufferer of a critical searching accident in 1987, he managed to make a comeback and win biking’s best race in 1989 and 1990.

He additionally received the World Cycling Championships in 1983 and 1989.

He stays the one American to have received the Tour with Lance Armstrong and Floyd Landis each stripped of their Tour titles.

Since retiring, LeMond has been a robust anti-doping advocate.

By Garrin Lambley © Agence France-Presse


Source link

Related Articles

Back to top button